Buyer for a small molecule CMO in Europe

Company to buy

• Size: Medium
• Revenue: 5-50 million EUR
• Location of the target company: Europe
• Reason for acquisition: The company wants a small molecule CMO to expand the company’s operations in Europe
• #CFIE PHB140

Overview of this buyer for a small molecule CMO in Europe

This buyer is a large CDMO company engaged in discovering and developing small molecule therapies. The company is interested in expanding its operations through the acquisition of a suitable CMO company in Europe.

Profile (strategy) of this buyer for a small molecule CMO in Europe

The buyer is a large company with more than 10 years of history focused on drug discovery. The company provides its clients with a broad range of services, from target validation to a selection of clinical candidates. The company offers a fully integrated drug discovery program including medicinal and synthetic chemistry, computer-aided drug design, structural biology, in vitro and in vivo pharmacology, ADME/DMPK, toxicology, and analytical testing. Besides drug discovery, the company also offers services in different areas such as research and development and regulatory studies. The company has been developing new molecules and new solutions for the biggest pharmaceutical companies around the world for over a decade.

The company has its HQ in Europe and offices across the world, with two plants in Europe. The company has more than 12,000 square meters of facilities securing laboratory space for further growth. All the research sites are equipped with state-of-the-art devices and are conducted under good manufacturing practice (GMP) and good laboratory practice (GLP).

The company has a presence worldwide and more than 500 employees and upwards of 100 million euros in revenue.

Activities and products of the target

The buyer is looking for a CMO company in Europe, especially in Central and Eastern Europe, but will not discard any other options. An interesting company to this buyer would be a mid-sized CMO company focused on health care and biotechnology with GMP certification. The company should have a good EBITDA margin and be profitable.

Highlights of this buyer for a small molecule CMO in Europe

• More than 10 years of history
• Stock listed company
• Revenue of 100+ million EUR
• Acquisition background
• Worldwide presence

Information about this buyer for a small molecule CMO in Europe

Feel free to contact us for more information regarding this buyer for a small molecule CMO in Europe or if you know possible interested or suitable parties. For more buyers for a small molecule CMO in Europe, please visit the section pharmaceutical buyers. For pharmaceutical manufacturing firms for sale visit the section pharmaceutical companies for sale.

More information on this buyer for a small molecule CMO in Europe

Please get in touch if you are interested in learning more about this buyer for a small molecule CMO in Europe. For more cmo companies for sale please visit the section cmo companies for sale. For other cmo buyers, please visit the section cmo companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.